www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 24 Apr 2026 18:04:42 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netWed, 22 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-to-present-data-on-obefazimod-at-digestive-disease-week-15628075

EQS-News: ABIVAX / Key word(s): Conference Abivax to Present Data on Obefazimod at Digestive Disease Week® 22.04.2026 / 22:05 CET/CEST The issuer is solely responsible for ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-to-present-data-on-obefazimod-at-digestive-disease-week-15628075Mon, 20 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents-15621989 EQS-News: ABIVAX / Key word(s): AGM/EGM Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents 20.04.2026 / 22:05 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents-15621989Wed, 01 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies-15590201 EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies 01.04.2026 / 22:05 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies-15590201Fri, 27 Mar 2026 10:50:00 +0100https://www.finanzen.net/nachricht/fonds/wochenschwerpunkt-trampolin-boerse-15580608https://www.finanzen.net/nachricht/fonds/wochenschwerpunkt-trampolin-boerse-15580608Thu, 26 Mar 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/abivax-sa-bilanzvorlage-zum-letzten-quartal-15577417Abivax SA hat am 23.03.2026 die Bilanz zum am 31.12.2025 abgelaufenen Quartal präsentiert.Das Ergebnis je Aktie fiel für das Gesamtjahr negativ aus. Der Verlust je Papier wurde auf 4,830 EUR beziffert. Im Vorjahr ... ]]>https://www.finanzen.net/nachricht/aktien/abivax-sa-bilanzvorlage-zum-letzten-quartal-15577417Mon, 23 Mar 2026 21:05:03 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-full-year-2025-financial-results-and-provides-business-updates-15572465 EQS-News: ABIVAX / Key word(s): Annual Results Abivax Announces Full Year 2025 Financial Results and Provides Business Updates 23.03.2026 / 21:05 CET/CEST The issuer is solely ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-full-year-2025-financial-results-and-provides-business-updates-15572465Sat, 21 Feb 2026 12:00:04 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-presents-first-evidence-of-anti-fibrotic-activity-for-obefazimod-alongside-new-clinical-efficacy-and-safety-analyses-in-inflammatory-bowel-disease-at-ecco-2026-15507571 EQS-News: ABIVAX / Key word(s): Study results Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-presents-first-evidence-of-anti-fibrotic-activity-for-obefazimod-alongside-new-clinical-efficacy-and-safety-analyses-in-inflammatory-bowel-disease-at-ecco-2026-15507571Fri, 20 Feb 2026 09:15:00 +0100https://www.finanzen.net/nachricht/aktien/small-cap-statt-big-tech-mit-nebenwerten-auf-der-ueberholspur-15505342https://www.finanzen.net/nachricht/aktien/small-cap-statt-big-tech-mit-nebenwerten-auf-der-ueberholspur-15505342Wed, 14 Jan 2026 13:45:00 +0100https://www.finanzen.net/nachricht/fonds/bestseller-wikifolios-im-dezember-15414757https://www.finanzen.net/nachricht/fonds/bestseller-wikifolios-im-dezember-15414757Mon, 12 Jan 2026 22:11:40 +0100https://www.finanzen.net/nachricht/aktien/maerkte-usa-gut-behauptet-aufregung-um-zwist-trump-powell-legt-sich-15410766DOW JONES--Mit kleinen Kursgewinnen haben die US-Börsen den Handel am Montag beendet. Die Verschärfung des Konflikts zwischen US-Präsident Donald Trump und US-Notenbankpräsident Jerome Powell hatte die Kurse anfangs belastete, ... ]]>https://www.finanzen.net/nachricht/aktien/maerkte-usa-gut-behauptet-aufregung-um-zwist-trump-powell-legt-sich-15410766